Law Firm · Petitioner PracticeVICP Petitioner PracticeLast verified
Cases filed
1
Comp rate
100%
Total awarded
$70K
Tenure
2016
⚠Heads up: The case docket, statistics, and overview below are compiled from AI-extracted data. Specific figures (case counts, awards, outcomes) may contain errors. Verify with the firm directly or with source court records before relying on them.
Chicago Kent is a U.S. law firm whose name appears on 1 petition in the National Vaccine Injury Compensation Program. The single recorded filing dates to 2016; compensation rate of 100%. Cases on file have produced $70K in total awards. The attorneys appearing on this firm's docket include Edward M. Kraus.
AI-generated overview · may contain errors. Verify details with the firm directly before relying on them.
Answers built from this firm's public case docket.
How do I find a good VICP lawyer?
Most petitioners hire counsel because the program's evidentiary burden, expert-witness requirements, and procedural rules are complex. Reasonable attorney fees in VICP cases are paid by the program — not by the petitioner — under 42 U.S.C. § 300aa-15(e)(1), so engaging counsel does not reduce a successful petitioner's recovery. You can submit a free inquiry → to have your case forwarded to attorneys with VICP experience, or research Chicago Kent's case history below.
How many VICP cases has Chicago Kent filed?
Chicago Kent has filed 1 petitions in the U.S. Vaccine Injury Compensation Program with publicly-available decisions, between 2016 and 2016.
What is Chicago Kent's compensation rate?
Chicago Kent's overall compensation rate across 1 VICP cases is 100% (1 compensated).
How much has Chicago Kent won in VICP cases?
Cases filed by Chicago Kent have resulted in $70K in total compensation awards from the U.S. Vaccine Injury Compensation Program (visible-in-public-decisions only).
What kinds of vaccine injury cases does Chicago Kent handle?
Based on the cases on file, Chicago Kent's practice includes SIRVA (shoulder injury related to vaccine administration), among other vaccine-related conditions.